期刊文献+

基于系统生物网络研究固本通络方治疗IgA肾病的分子机制 被引量:4

Molecular mechanism of Guben Tongluo Decoction in treating IgA nephropathy depending on a systemic biology network
原文传递
导出
摘要 目的:应用系统生物学方法研究固本通络方治疗IgA肾病的分子机制。方法:从中药分子靶标数据库中获取固本通络方潜在的药靶信息,与OMIM和IPA数据库中已知IgA肾病致病基因进行比较及功能富集分析,并构建分子调控网络。结果:固本通络方有3 851个相关蛋白,IgA肾病有25个相关蛋白,有16个蛋白为二者共有;有6个组分(黄芪、丹参、桃仁、女贞子、白茅根、鬼箭羽)作用于这16个二者共有的相关蛋白,黄芪位于该作用网络的中心;主要作用途径是影响肾素-血管紧张素系统和B细胞分泌IgA。另外,未被固本通络方覆盖的9个IgA肾病相关蛋白在细胞周期调控等生物过程中亦发挥重要作用。结论:固本通络方治疗IgA肾病可能与影响肾素-血管紧张素系统和B细胞分泌IgA有关。 Objective: To study molecular mechanism of Guben Tongluo Decoction(GBTL) in treating IgA nephropathy(IgAN) depending on a systemic biology network approach. Methods: Known IgAN associated protein annotated in OMIM and IPA database were compared with potential targets of nine ingredients in GBTL obtained from TCMID database, then performed functional enrichment analysis and constructed molecular regulation network. Results: From 25 IgAN-associated proteins, 16 were simultaneously seen in 3 851 potential targets of GBTL. Moreover, 6 out of 9 ingredients(Astragalus, Salvia miltiorrhiza, Peach kernel, Glossy privet fruit, Lalang grass rhizome, Euonymus alatus) in GBTL acted on the 16 common proteins, with Astragalus in a central position of the regulation network. The actions of 6 ingredients focused on the Renin-Angiotensin system and IgA secreted by B cell. Additionally, the remaining 9 proteins relevant to IgAN played key roles in the regulation of biological process like cell cycle. Conclusion: The mechanism underlying GBTL Decoction treating IgA nephropathy may be associated with the regulation of Renin-Angiotensin system and IgA secreted by B cell.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2016年第8期3282-3286,共5页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 上海市科委自然科学基金项目(No.12ZR1432400) 中医临床重点项目(No.14401972203) 中医引导项目(No.15401930100) 上海市卫生和计划生育委员会科研课题(No.201440488) 上海市中医药三年行动计划(No.ZY3-JSFC-2-1029) 上海市高级中西医结合人才培养项目(No.ZYSNXD012-RC-ZXY003) 上海市中医临床肾病基地(No.ZY3-LCPT-1-1006)~~
关键词 中医药 固本通络方 IG A肾病 蛋白质 网络 分子机制 功能富集分析 Traditional Chinese medicine Guben Tongluo Decoction IgA nephropathy Proteins Network Molecular mechanism Functional enrichment analysis
  • 相关文献

参考文献3

二级参考文献29

  • 1[1]Schena FP.IgA Nephropathies.In: Cameron JS, Davison AM.Oxford Textbook of Clinal Nephrology.Vol I,1 st ed,Oxford,Oxford University Press,1992,339-369.
  • 2[2]Li leishi.End-sta renal disease in China.Kidney Int,1996,49:287.
  • 3Schena FP. leA Nephropathies. In: Cameron JS, Davison AM. Oxford Textbook of Clinal Nephrology. Vol I , 1st ed.Oxford, Oxford University Press, 1992,339 - 369.
  • 4Li Leishi. End - sta renal disease in China. Kidney Int,1996,49: 287.
  • 5Barratt J,Feehally J. IgA nephropathy[J]. J Am Soc Nephrol, 2005,16(7) :2088-2097.
  • 6Matousovic K, Konecny K, Mestecky J, et al. IgA nephropathy. Significance of immunoglobulin A glycosylation inpathogenesis and clinical presentation [J]. Cas Lek Cesk, 2002,141(23) :729-734.
  • 7Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN) [J]. Kidney Int, 2004,65 (5) : 1544-1547.
  • 8Lai KN,Tang SC,Guh JY,et al. Polymeric IgAl from patients with IgA nephropathy upregulates transforming growth factor- β synthesis and signal transduction in human mesangial cells via the renin-angiotensin system[J]. J Am Soc Nephrol, 2003, 14(12) :3127-3137.
  • 9Chan LY, Leung JC, Tang SC, et al. Tubular expression of angiotensin Ⅱ receptors and their regulation in IgA nephropathy [J]. J Am Soc Nephrol, 2005,16(8) : 2306-2317.
  • 10Buraezynska M, Ksiazek P, Drop A, et al. Cenetie polymorphisms of the renin-angiotensin system in end-stage renal disease [J]. Nephrol Dial Transplant, 2006,21 (4) : 979- 983.

共引文献31

同被引文献101

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部